Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences

SafetyAlerts
November 21, 2002

Eli Lilly Has Recalled Cefuroxime

(SafetyAlerts) - The Food and Drug Administration (FDA) has released the following information.

PRODUCT
1) Cefuroxime for Injection, USP, 1.5g, Novaplus brand,
Infusion Bottle, For Intravenous Use, Rx only, Recall # D-050-3.
2 A) Cefuroxime for Injection USP, 7.5g, Novaplus brand,
Pharmacy Bulk Package, For Intravenous Use,
Not For Direct Infusion, Rx only, Recall # D-051-3;
2 B) Cefuroxime for Injection USP, 7.5g, AmeriNet Choice brand, Pharmacy Bulk Package, For Intravenous Use,
Not For Direct Infusion, Rx only.
3) Kefurox (Cefuroxime for Injection USP), 7.5g, Lilly brand, Pharmacy Bulk Package, For Intravenous Use,
Not For Direct Infusion, Rx only, Recall # D-052-3.

CODE
Lot No. (Exp. date)
Cefuroxime for Injection, USP, 1.5g
W8740Y3(1-Jan-03)

Cefuroxime for Injection USP, 7.5g
F3530Y2 (1-Mar-03), Z4420Y1 (1-Apr-03), Z4460Y1 (1-Apr-03),
Z4460Y6 (1-Apr-03), F0290Y2 (1-Jan-03), F3530Y1 (1-Mar-03),
Z4430Y5 (1-May-03).

Kefurox (Cefuroxime for Injection USP), 7.5g
F0290Y3 (1-Jan-03), F3530Y3 (1-Mar-03), Z4420Y2 (1-Apr-03).

RECALLING FIRM/MANUFACTURER
Recalling Firm: Eli Lilly and Co., Indianapolis, IN, by letters on October 7, 2002.
Manufacturer: Eli Lilly Italia, S.P.A., Sesto Fiorentino, Italy.
Firm initiated recall is ongoing.

REASON
Discoloration: product exceeded specification for color level (18 month stability).

VOLUME OF PRODUCT IN COMMERCE
25,500 units.

DISTRIBUTION
Nationwide.

 

 
Selected Recent Recalls


Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.